Concepts (249)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, GABA-A | 20 | 2021 | 89 | 4.970 |
Why?
|
| Receptors, Kainic Acid | 6 | 2015 | 24 | 2.350 |
Why?
|
| Protein Subunits | 12 | 2013 | 99 | 2.030 |
Why?
|
| gamma-Aminobutyric Acid | 12 | 2011 | 208 | 1.340 |
Why?
|
| Anticonvulsants | 4 | 2013 | 223 | 1.330 |
Why?
|
| Membrane Potentials | 7 | 2015 | 200 | 1.110 |
Why?
|
| GABA-A Receptor Agonists | 7 | 2017 | 13 | 1.090 |
Why?
|
| Dioxolanes | 3 | 2011 | 8 | 1.080 |
Why?
|
| Membrane Proteins | 4 | 2015 | 617 | 1.050 |
Why?
|
| Protein Multimerization | 3 | 2013 | 71 | 0.950 |
Why?
|
| HEK293 Cells | 11 | 2017 | 326 | 0.950 |
Why?
|
| Ion Channel Gating | 4 | 2012 | 42 | 0.900 |
Why?
|
| Glutamic Acid | 5 | 2015 | 332 | 0.690 |
Why?
|
| Pentobarbital | 3 | 2010 | 19 | 0.680 |
Why?
|
| Patch-Clamp Techniques | 8 | 2015 | 204 | 0.660 |
Why?
|
| GABA Agonists | 3 | 2010 | 23 | 0.640 |
Why?
|
| Recombinant Proteins | 10 | 2015 | 742 | 0.620 |
Why?
|
| Transfection | 8 | 2014 | 782 | 0.540 |
Why?
|
| Epilepsy | 2 | 2013 | 336 | 0.510 |
Why?
|
| GABA Agents | 2 | 2012 | 18 | 0.490 |
Why?
|
| Mutation | 7 | 2014 | 1213 | 0.490 |
Why?
|
| Drug Synergism | 2 | 2013 | 260 | 0.480 |
Why?
|
| Neurotoxins | 1 | 2014 | 30 | 0.470 |
Why?
|
| Kainic Acid | 1 | 2014 | 44 | 0.470 |
Why?
|
| Rats | 10 | 2013 | 5300 | 0.450 |
Why?
|
| Aminopyridines | 1 | 2013 | 26 | 0.450 |
Why?
|
| Bone Neoplasms | 2 | 2006 | 100 | 0.440 |
Why?
|
| Thiophenes | 1 | 2013 | 76 | 0.430 |
Why?
|
| Dose-Response Relationship, Drug | 8 | 2015 | 1745 | 0.410 |
Why?
|
| Lignans | 1 | 2012 | 10 | 0.410 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2012 | 15 | 0.410 |
Why?
|
| Animals | 23 | 2022 | 20881 | 0.400 |
Why?
|
| Cell Membrane | 1 | 2013 | 525 | 0.400 |
Why?
|
| Drug Therapy, Combination | 1 | 2013 | 649 | 0.390 |
Why?
|
| Biphenyl Compounds | 1 | 2012 | 184 | 0.380 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2011 | 8 | 0.380 |
Why?
|
| Histamine | 1 | 2011 | 52 | 0.380 |
Why?
|
| Wakefulness | 1 | 2011 | 75 | 0.370 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2020 | 199 | 0.360 |
Why?
|
| Hippocampus | 2 | 2022 | 471 | 0.360 |
Why?
|
| Anti-Anxiety Agents | 1 | 2011 | 107 | 0.360 |
Why?
|
| Benzodiazepines | 1 | 2011 | 130 | 0.350 |
Why?
|
| RNA Editing | 1 | 2009 | 5 | 0.340 |
Why?
|
| Cell Line | 7 | 2011 | 1752 | 0.330 |
Why?
|
| Humans | 29 | 2022 | 68618 | 0.320 |
Why?
|
| Calcium | 1 | 2012 | 929 | 0.310 |
Why?
|
| Binding Sites | 4 | 2014 | 631 | 0.300 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2015 | 266 | 0.290 |
Why?
|
| Allosteric Regulation | 4 | 2017 | 58 | 0.290 |
Why?
|
| Melanoma, Experimental | 2 | 2020 | 95 | 0.280 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2006 | 32 | 0.270 |
Why?
|
| Neurons | 1 | 2012 | 881 | 0.270 |
Why?
|
| Amiloride | 2 | 2004 | 22 | 0.270 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2006 | 66 | 0.260 |
Why?
|
| Amino Acid Sequence | 4 | 2013 | 1083 | 0.260 |
Why?
|
| Mice | 13 | 2022 | 8474 | 0.250 |
Why?
|
| Glycoproteins | 1 | 2006 | 238 | 0.240 |
Why?
|
| Cell Line, Transformed | 3 | 2009 | 100 | 0.230 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 2 | 2014 | 12 | 0.230 |
Why?
|
| Fluoxetine | 1 | 2003 | 40 | 0.220 |
Why?
|
| Structure-Activity Relationship | 3 | 2012 | 420 | 0.220 |
Why?
|
| 3',5'-Cyclic-GMP Phosphodiesterases | 1 | 2022 | 10 | 0.210 |
Why?
|
| Interleukin-2 | 2 | 2020 | 133 | 0.200 |
Why?
|
| Protein Binding | 3 | 2013 | 1027 | 0.190 |
Why?
|
| Tourette Syndrome | 1 | 2021 | 8 | 0.190 |
Why?
|
| Molecular Sequence Data | 3 | 2013 | 1447 | 0.190 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2020 | 32 | 0.180 |
Why?
|
| Antineoplastic Agents | 2 | 2020 | 1070 | 0.170 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2020 | 376 | 0.170 |
Why?
|
| Cognitive Dysfunction | 1 | 2022 | 176 | 0.170 |
Why?
|
| Osteoclasts | 3 | 2006 | 132 | 0.160 |
Why?
|
| Mice, Inbred BALB C | 4 | 2018 | 532 | 0.160 |
Why?
|
| Point Mutation | 3 | 2014 | 97 | 0.160 |
Why?
|
| Behavior, Animal | 1 | 2021 | 470 | 0.150 |
Why?
|
| Electric Stimulation | 2 | 2009 | 218 | 0.150 |
Why?
|
| Muscle, Smooth | 1 | 2018 | 117 | 0.150 |
Why?
|
| Gene Expression Regulation | 3 | 2013 | 1293 | 0.150 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 2550 | 0.150 |
Why?
|
| Fibroblasts | 1 | 2002 | 902 | 0.140 |
Why?
|
| Oxazoles | 1 | 2017 | 17 | 0.140 |
Why?
|
| Ligands | 2 | 2018 | 317 | 0.140 |
Why?
|
| Breast Neoplasms | 1 | 2006 | 1536 | 0.140 |
Why?
|
| Kinetics | 3 | 2007 | 1047 | 0.130 |
Why?
|
| Lung Neoplasms | 2 | 2020 | 1173 | 0.130 |
Why?
|
| Immunotherapy | 2 | 2020 | 215 | 0.130 |
Why?
|
| Prostatic Neoplasms | 1 | 2002 | 778 | 0.130 |
Why?
|
| Analgesics | 1 | 2017 | 118 | 0.130 |
Why?
|
| Excitatory Amino Acid Agents | 1 | 2015 | 20 | 0.130 |
Why?
|
| Electrophysiology | 2 | 2007 | 160 | 0.130 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2014 | 25 | 0.120 |
Why?
|
| Asthma | 1 | 2018 | 345 | 0.120 |
Why?
|
| Neural Inhibition | 1 | 2014 | 80 | 0.110 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2014 | 128 | 0.110 |
Why?
|
| Glutamates | 1 | 2013 | 41 | 0.110 |
Why?
|
| Mutant Proteins | 1 | 2013 | 45 | 0.110 |
Why?
|
| Mice, Nude | 2 | 2006 | 294 | 0.110 |
Why?
|
| Indoles | 1 | 2014 | 146 | 0.110 |
Why?
|
| Lung | 1 | 2018 | 849 | 0.110 |
Why?
|
| Sulfonamides | 1 | 2014 | 141 | 0.110 |
Why?
|
| Membrane Glycoproteins | 2 | 2006 | 370 | 0.110 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 65 | 0.100 |
Why?
|
| Forkhead Transcription Factors | 1 | 2012 | 94 | 0.100 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2012 | 25 | 0.100 |
Why?
|
| Glioblastoma | 1 | 2015 | 219 | 0.100 |
Why?
|
| Action Potentials | 1 | 2013 | 223 | 0.100 |
Why?
|
| Kynurenic Acid | 1 | 2011 | 26 | 0.100 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2012 | 110 | 0.100 |
Why?
|
| Inflammation | 1 | 2018 | 1030 | 0.100 |
Why?
|
| Flow Cytometry | 2 | 2012 | 489 | 0.100 |
Why?
|
| Receptor Cross-Talk | 1 | 2011 | 16 | 0.100 |
Why?
|
| Spinal Nerves | 1 | 2011 | 3 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 331 | 0.100 |
Why?
|
| Neurons, Afferent | 1 | 2011 | 32 | 0.090 |
Why?
|
| Brain Neoplasms | 1 | 2015 | 371 | 0.090 |
Why?
|
| Neuralgia | 1 | 2011 | 27 | 0.090 |
Why?
|
| Syndrome | 1 | 2011 | 255 | 0.090 |
Why?
|
| Receptors, Opioid, mu | 1 | 2011 | 70 | 0.090 |
Why?
|
| Synaptic Transmission | 1 | 2012 | 236 | 0.090 |
Why?
|
| Cell Division | 2 | 2014 | 541 | 0.090 |
Why?
|
| Drug Interactions | 1 | 2011 | 289 | 0.090 |
Why?
|
| Cells, Cultured | 3 | 2007 | 2673 | 0.090 |
Why?
|
| Plasmids | 1 | 2011 | 258 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 4 | 2021 | 2791 | 0.090 |
Why?
|
| Tumor Cells, Cultured | 2 | 2020 | 852 | 0.080 |
Why?
|
| Isoleucine | 1 | 2009 | 7 | 0.080 |
Why?
|
| Methionine | 1 | 2009 | 36 | 0.080 |
Why?
|
| Dye Dilution Technique | 1 | 2008 | 3 | 0.080 |
Why?
|
| Antigens | 1 | 2008 | 90 | 0.080 |
Why?
|
| Diazepam | 1 | 2008 | 23 | 0.080 |
Why?
|
| Neoplasm Transplantation | 2 | 2014 | 160 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 322 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2018 | 226 | 0.080 |
Why?
|
| Etomidate | 1 | 2006 | 2 | 0.070 |
Why?
|
| Apoptosis | 2 | 2020 | 1641 | 0.070 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 2006 | 15 | 0.070 |
Why?
|
| Osteoprotegerin | 1 | 2006 | 11 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 1851 | 0.070 |
Why?
|
| Cell Growth Processes | 1 | 2006 | 40 | 0.070 |
Why?
|
| Transplantation, Heterologous | 1 | 2006 | 122 | 0.070 |
Why?
|
| Cell Proliferation | 3 | 2020 | 1174 | 0.070 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2006 | 100 | 0.070 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2006 | 65 | 0.070 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 1033 | 0.060 |
Why?
|
| Osteoblasts | 2 | 2004 | 99 | 0.060 |
Why?
|
| Receptors, Cell Surface | 1 | 2006 | 248 | 0.060 |
Why?
|
| RNA Splicing | 1 | 2004 | 32 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2006 | 447 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 710 | 0.060 |
Why?
|
| Male | 9 | 2018 | 37321 | 0.060 |
Why?
|
| Binding, Competitive | 1 | 2004 | 165 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2004 | 146 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2006 | 626 | 0.060 |
Why?
|
| Mammals | 1 | 2003 | 47 | 0.050 |
Why?
|
| Exoribonucleases | 1 | 2022 | 6 | 0.050 |
Why?
|
| Cholinergic Agents | 1 | 2022 | 12 | 0.050 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 2002 | 7 | 0.050 |
Why?
|
| Conserved Sequence | 1 | 2002 | 67 | 0.050 |
Why?
|
| Endocannabinoids | 1 | 2022 | 32 | 0.050 |
Why?
|
| Electric Conductivity | 1 | 2002 | 87 | 0.050 |
Why?
|
| Furosemide | 1 | 2002 | 45 | 0.050 |
Why?
|
| DNA Methylation | 2 | 2015 | 193 | 0.050 |
Why?
|
| Sialoglycoproteins | 1 | 2002 | 24 | 0.050 |
Why?
|
| Osteopontin | 1 | 2002 | 28 | 0.050 |
Why?
|
| Lysine | 1 | 2002 | 96 | 0.050 |
Why?
|
| Cell Transplantation | 1 | 2002 | 22 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2022 | 1664 | 0.050 |
Why?
|
| Diuretics | 1 | 2002 | 97 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2002 | 246 | 0.050 |
Why?
|
| Bone Marrow | 1 | 2002 | 168 | 0.050 |
Why?
|
| Tics | 1 | 2021 | 2 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2004 | 597 | 0.050 |
Why?
|
| Tibia | 1 | 2002 | 93 | 0.050 |
Why?
|
| Blinking | 1 | 2021 | 8 | 0.050 |
Why?
|
| Collagen Type I | 1 | 2002 | 175 | 0.050 |
Why?
|
| Reflex, Startle | 1 | 2021 | 39 | 0.050 |
Why?
|
| Oxytocin | 1 | 2022 | 124 | 0.050 |
Why?
|
| Cataplexy | 1 | 2021 | 25 | 0.050 |
Why?
|
| Time Factors | 1 | 2009 | 4655 | 0.050 |
Why?
|
| Benzazepines | 1 | 2021 | 104 | 0.040 |
Why?
|
| Genetic Engineering | 1 | 2020 | 41 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2020 | 282 | 0.040 |
Why?
|
| Killer Cells, Natural | 1 | 2020 | 94 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 1753 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2020 | 228 | 0.040 |
Why?
|
| Neoplasm Metastasis | 2 | 2012 | 306 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2012 | 266 | 0.040 |
Why?
|
| Dopamine | 1 | 2021 | 474 | 0.040 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2018 | 12 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2020 | 397 | 0.040 |
Why?
|
| Ovalbumin | 1 | 2018 | 33 | 0.040 |
Why?
|
| Constriction | 1 | 2018 | 37 | 0.040 |
Why?
|
| Guinea Pigs | 1 | 2018 | 124 | 0.040 |
Why?
|
| Eosinophils | 1 | 2018 | 60 | 0.040 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2018 | 117 | 0.040 |
Why?
|
| Female | 5 | 2020 | 38074 | 0.040 |
Why?
|
| Mice, Inbred ICR | 1 | 2017 | 44 | 0.040 |
Why?
|
| Allosteric Site | 1 | 2017 | 17 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2012 | 498 | 0.030 |
Why?
|
| Prefrontal Cortex | 1 | 2021 | 640 | 0.030 |
Why?
|
| CD3 Complex | 1 | 2015 | 35 | 0.030 |
Why?
|
| Macrophages | 1 | 2018 | 647 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2014 | 60 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2014 | 138 | 0.030 |
Why?
|
| Cytokines | 1 | 2018 | 866 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 536 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2014 | 238 | 0.030 |
Why?
|
| Aged | 2 | 2022 | 14862 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2014 | 112 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2015 | 714 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 247 | 0.030 |
Why?
|
| CTLA-4 Antigen | 1 | 2012 | 45 | 0.030 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2012 | 28 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 307 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 320 | 0.020 |
Why?
|
| Vaccination | 1 | 2012 | 189 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2012 | 384 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 2009 | 60 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2011 | 244 | 0.020 |
Why?
|
| Prognosis | 1 | 2015 | 2093 | 0.020 |
Why?
|
| Markov Chains | 1 | 2009 | 133 | 0.020 |
Why?
|
| Succinimides | 1 | 2008 | 11 | 0.020 |
Why?
|
| Fluoresceins | 1 | 2008 | 31 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2008 | 144 | 0.020 |
Why?
|
| Organic Chemicals | 1 | 2008 | 77 | 0.020 |
Why?
|
| Adaptation, Biological | 1 | 2007 | 14 | 0.020 |
Why?
|
| Brain | 1 | 2018 | 2176 | 0.020 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2006 | 14 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2011 | 2083 | 0.020 |
Why?
|
| Interleukin-11 | 1 | 2004 | 13 | 0.020 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2004 | 17 | 0.020 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2004 | 26 | 0.020 |
Why?
|
| Chondrocytes | 1 | 2004 | 27 | 0.010 |
Why?
|
| Wnt Proteins | 1 | 2004 | 57 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2004 | 201 | 0.010 |
Why?
|
| RANK Ligand | 1 | 2004 | 73 | 0.010 |
Why?
|
| Calcitriol | 1 | 2004 | 106 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2006 | 954 | 0.010 |
Why?
|
| Parathyroid Hormone | 1 | 2004 | 117 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2004 | 145 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2004 | 217 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 166 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 492 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 2077 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 507 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2004 | 330 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2004 | 434 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2004 | 368 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 21147 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2004 | 2689 | 0.010 |
Why?
|